[Cerebrospinal meningitis and anti-meningococcal vaccination].
D000293:Adolescent; D000328:Adult; D000349:Africa; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008581:Meningitis / Q000209:etiology; D008585:Meningitis, Meningococcal / Q000188:drug therapy / Q000276:immunology / Q000401:mortality / Q000517:prevention & control; D008589:Meningococcal Infections / Q000453:epidemiology; D008875:Middle Aged; D008887:Military Medicine; D009018:Morocco; D013449:Sulfonamides / Q000627:therapeutic use; D014481:United States; D014611:Vaccination
D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines; D013449:Sulfonamides
Méningite cérébro-spinale et vaccination antiméningococcique.